BIOMAT Database Logo BIOMAT Database Logo

Norfloxacin-loaded chitosan sponges as wound dressing material. 2004

Emir B Denkbaş, and Eylem Oztürk, and Nalan Ozdemir, and Kaan Keçeci, and Canan Agalar
Chemistry Department, Biochemistry Division Hacettepe University, Ankara, Turkey.

The aim of this study was the preparation and characterization of chitosan sponges including a model antibiotic (i.e., norfloxacin). The chitosan sponges were prepared by a solvent evaporation method. The matrix was also cross-linked during the preparation. The results indicated that the chitosan sponges were in the fibrillar structure. The swelling behavior, norfloxacin loading, in vitro release characteristics, and antibacterial activity were determined. The effects of cross-linker concentration, norfloxacin/chitosan ratio, chitosan molecular weight, and base concentration were investigated. The most effective parameter was found to be the degree of neutralization. It was also observed that the equilibrium swelling ratio decreased with increasing cross-linking density. The norfloxacin release was found to be swelling controlled initially and diffusion controlled at the extended release periods. It was also found that the antibacterial activity was directly proportional to the release rate.

UI MeSH Term Description Entries
D008422 Materials Testing The testing of materials and devices, especially those used for PROSTHESES AND IMPLANTS; SUTURES; TISSUE ADHESIVES; etc., for hardness, strength, durability, safety, efficacy, and biocompatibility. Biocompatibility Testing,Biocompatible Materials Testing,Hemocompatibility Testing,Testing, Biocompatible Materials,Testing, Hemocompatible Materials,Hemocompatibility Testings,Hemocompatible Materials Testing,Materials Testing, Biocompatible,Materials Testing, Hemocompatible,Testing, Biocompatibility,Testing, Hemocompatibility,Testing, Materials,Testings, Biocompatibility
D009643 Norfloxacin A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE. AM-0715,AM-715,MK-0366,MK-366,MK0366,MK366,Noroxin,AM 0715,AM 715,AM0715,MK 0366,MK 366
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002686 Chitin A linear polysaccharide of beta-1->4 linked units of ACETYLGLUCOSAMINE. It is the second most abundant biopolymer on earth, found especially in INSECTS and FUNGI. When deacetylated it is called CHITOSAN.
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations
D000327 Adsorption The adhesion of gases, liquids, or dissolved solids onto a surface. It includes adsorptive phenomena of bacteria and viruses onto surfaces as well. ABSORPTION into the substance may follow but not necessarily. Adsorptions
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents

Related Publications

Emir B Denkbaş, and Eylem Oztürk, and Nalan Ozdemir, and Kaan Keçeci, and Canan Agalar
Chitosan sponges loaded with metformin and microalgae as dressing for wound healing: A study in diabetic bio-models.
January 2024, International journal of biological macromolecules,
Emir B Denkbaş, and Eylem Oztürk, and Nalan Ozdemir, and Kaan Keçeci, and Canan Agalar
Carboxymethyl konjac glucomannan - crosslinked chitosan sponges for wound dressing.
June 2018, International journal of biological macromolecules,
Emir B Denkbaş, and Eylem Oztürk, and Nalan Ozdemir, and Kaan Keçeci, and Canan Agalar
Chitosan/polyethylene glycol diacrylate films as potential wound dressing material.
December 2008, International journal of biological macromolecules,
Emir B Denkbaş, and Eylem Oztürk, and Nalan Ozdemir, and Kaan Keçeci, and Canan Agalar
Surface fluid-swellable chitosan fiber as the wound dressing material.
January 2016, Carbohydrate polymers,
Emir B Denkbaş, and Eylem Oztürk, and Nalan Ozdemir, and Kaan Keçeci, and Canan Agalar
Chrysin loaded polycaprolactone-chitosan electrospun nanofibers as potential antimicrobial wound dressing.
February 2024, International journal of biological macromolecules,
Emir B Denkbaş, and Eylem Oztürk, and Nalan Ozdemir, and Kaan Keçeci, and Canan Agalar
Construction of silver sulfadiazine loaded chitosan composite sponges as potential wound dressings.
February 2017, Carbohydrate polymers,
Emir B Denkbaş, and Eylem Oztürk, and Nalan Ozdemir, and Kaan Keçeci, and Canan Agalar
Hypericum perforatum incorporated chitosan films as potential bioactive wound dressing material.
September 2017, International journal of biological macromolecules,
Emir B Denkbaş, and Eylem Oztürk, and Nalan Ozdemir, and Kaan Keçeci, and Canan Agalar
Application of tetracycline hydrochloride loaded-fungal chitosan and Aloe vera extract based composite sponges for wound dressing.
November 2018, Journal of advanced research,
Emir B Denkbaş, and Eylem Oztürk, and Nalan Ozdemir, and Kaan Keçeci, and Canan Agalar
Kaolin-loaded chitosan/polyvinyl alcohol electrospun scaffold as a wound dressing material: in vitro and in vivo studies.
May 2020, Journal of wound care,
Emir B Denkbaş, and Eylem Oztürk, and Nalan Ozdemir, and Kaan Keçeci, and Canan Agalar
Chitosan-protein scaffolds loaded with lysostaphin as potential antistaphylococcal wound dressing materials.
September 2014, Journal of applied microbiology,
Copied contents to your clipboard!